SCHEMBL472913

SCHEMBL472913

C=C(O)Cc1ccnc2ccccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.58
▸ LOXL2 Q9Y4K0 1/20 0.56
▸ NCF1 P14598 1/20 0.46
▸ KDM4E B2RXH2 2/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ LMNA P02545 2/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ HTR1A P08908 2/20 0.44
▸ ADRA1D P25100 2/20 0.44
▸ ADRA1A P35348 2/20 0.44
▸ ADRA1B P35368 2/20 0.44
▸ FERMT2 Q96AC1 1/20 0.44
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ HIF1A Q16665 1/20 0.43
▸ FAAH O00519 1/20 0.41
▸ PTPN1 P18031 1/20 0.41
▸ PTPN11 Q06124 1/20 0.41
▸ MAPT P10636 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5456634 0.81 CYP1A2 (0.67) CYP1A2LOXL2NCF1KDM4EALDH1A1
SCHEMBL607974 0.81 LOXL2 (0.51) CYP1A2LOXL2NCF1KDM4EALDH1A1
Hydrochloric Acid SCHEMBL3805296 0.80 CYP1A2 (0.65) CYP1A2LOXL2NCF1KDM4EALDH1A1
SCHEMBL28001770 0.79 LOXL2 (0.58) CYP1A2LOXL2NCF1KDM4EALDH1A1
SCHEMBL31599195 0.78 LOXL2 (0.67) CYP1A2LOXL2NCF1KDM4EALDH1A1
SCHEMBL334360 0.78 LOXL2 (0.67) CYP1A2LOXL2NCF1KDM4EALDH1A1
SCHEMBL29987166 0.77 CYP1A2 (0.61) CYP1A2LOXL2NCF1KDM4EALDH1A1
SCHEMBL5239658 0.77 CYP1A2 (0.61) CYP1A2LOXL2NCF1KDM4EALDH1A1
SCHEMBL3775943 0.76 CYP1A2 (0.60) CYP1A2LOXL2NCF1KDM4EALDH1A1
SCHEMBL5508700 0.76 CYP1A2 (0.60) CYP1A2LOXL2NCF1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598651-A1 METHODS AND USES RELATING TO THE IDENTIFICATION OF COMPOUND ASSOCIATED WITH BACTERIAL INFECTION Sanofi-Aventis Deutschland GmbH (DE) 2013-06-05 — — EP disclosed
US-20130123360-A1 METHODS AND USES RELATING TO THE IDENTIFICATION OF COMPOUND ASSOCIATED WITH BACTERIAL INFECTION SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2013-05-16 — — US disclosed
WO-2012013621-A1 METHODS AND USES RELATING TO THE IDENTIFICATION OF COMPOUND ASSOCIATED WITH BACTERIAL INFECTION SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2012-02-02 — — WO disclosed
EP-2412819-A1 Methods and uses relating to the identification of compound associated with bacterial infection Sanofi-Aventis Deutschland GmbH (DE) 2012-02-01 — — EP disclosed
Send feedback